← All trials
NCT03522961
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 15, 2018
- Primary completion
- Jul 9, 2020
- Completion date
- Jul 9, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 142
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityReponsible party - principal investigator
- Harvard UniversityOverall official - principal investigator
- Theralogix LLCCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.